Cargando…
Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers
Biomarker directed selection of targeted anti-neoplastic agents such as immune checkpoint inhibitors, small molecule inhibitors and monoclonal antibodies form an important aspect of cancer treatment. Immunohistochemistry (IHC) analysis of the tumor tissue is the method of choice to evaluate the pres...
Autores principales: | Page, Raymond, Patil, Darshana, Akolkar, Dadasaheb, Murthy, Sudha S., Bendale, Kiran, Patil, Revati, Fulmali, Pradeep, Fulmali, Pooja, Adhav, Archana, Puranik, Sneha, Apurwa, Sachin, Datta, Vineet, Bose, Chirantan, Schuster, Stefan, John, Jinumary, Srinivasan, Ajay, Datar, Rajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205490/ https://www.ncbi.nlm.nih.gov/pubmed/35714131 http://dx.doi.org/10.1371/journal.pone.0270139 |
Ejemplares similares
-
Circulating ensembles of tumor‐associated cells: A redoubtable new systemic hallmark of cancer
por: Akolkar, Dadasaheb, et al.
Publicado: (2019) -
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
por: Limaye, Sewanti, et al.
Publicado: (2021) -
Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study
por: Patil, Darshana, et al.
Publicado: (2022) -
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
por: Crook, Timothy, et al.
Publicado: (2022) -
Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells
por: Limaye, Sewanti, et al.
Publicado: (2023)